Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2020 Aug 14;109(2):387–395. doi: 10.1016/j.ijrobp.2020.08.030

Table 3.

Modes of progression

LTC Oligoprogressor Polyprogressor
Total population 40.9% 36% 23.1%
No ADT 27.6% 44.8% 27.6%
Conventional imaging 46.1% 36.2% 17.7%
Enhanced imaging 36.3% 37.7% 26%

Abbreviations: ADT = androgen deprivation therapy; LTC = long-term control.